Cheng Yang
Digital Diagnostics Lead Takeda Pharmaceutical
Dr. Cheng Yang is the Digital Diagnostics Lead at Takeda’s Global R&D organization, based in Boston. He leads the global strategy and development of digital diagnostic devices and AI/ML-enabled software for disease diagnosis, screening, and treatment monitoring. Holding a Ph.D. in Analytical Chemistry and a Master’s in AI/ML, Dr. Yang has driven cross-functional initiatives linking diagnostics with therapeutic products. His work includes point-of-care tools, companion diagnostics, and AI-powered imaging and screening solutions. He also represents Takeda in the EU IHI-funded SEARCH consortium, advancing the use of synthetic health data to support the development and deployment of next-generation e-health solutions.
Seminars
- Exploring how AI and LLM technologies are being translated into regulated digital diagnostics to support disease screening, diagnosis, and long-term patient management
- Sharing considerations for turning algorithmic insights into clinically integrated, compliant software medical devices
- Highlighting key learnings from digital diagnostic tools that support therapeutic decision-making and enable real-world deployment across diverse care settings
